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S U M M A R Y
Objective: The objective of this study was to investigate the clinical characteristics of patients with
dengue viral infection during the 2008 outbreak in Lahore in order to better understand the clinical
pattern and severity of disease in Lahore.
Methods: We analyzed the clinical characteristics of 110 patients infected with dengue virus; data were
collected on standardized data collection sheets at two tertiary care hospitals from September to
December 2008. Dengue infection was conﬁrmed serologically or by real-time polymerase chain
reaction (RT-PCR).
Results: Out of the total of 110 dengue infected patients, 70 were male and 40 were female. The most
common symptoms included fever (100%), myalgia (68.2%), headache (55.5%), nausea (39.1%), skin rash
(53.6%), mucocutaneous hemorrhagic manifestations (58.2%), and ocular pain (20%). Classic dengue
fever (DF) was seen in 41.8% of the patients, 56.4% had dengue hemorrhagic fever (DHF), and only 1.8%
developed dengue shock syndrome (DSS). The mean duration of fever was 6 days. Thrombocytopenia,
leukopenia, and abnormal aspartate aminotransferase (AST)/alanine aminotransferase (ALT) were more
frequently encountered in DHF and DSS as compared to DF. Viral RNA detection was done by RT-PCR in
17 patients. Ten patients had DEN4, ﬁve had DEN2, and two had DEN3 serotypes. The majority of the
patients recovered completely without complications.
Conclusion: The high frequency of DHF during the 2008 outbreak and the presence of three different
dengue serotypes, emphasize the need to prevent and control dengue infection. Health authorities
should consider strengthening surveillance for dengue infection, given the potential for future outbreaks
with increased severity. It is also suggested that primary care physicians should be educated regarding
recognition of DHF and to identify patients at high risk of developing DHF and DSS.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Dengue viral infection is the most important arboviral disease
of humans; approximately 100million dengue fever (DF) cases and
several hundred thousand cases of dengue hemorrhagic fever
(DHF) occur annually.1 Dengue is one of themost frequent diseases
in travelers from endemic areas,2 and the large volume of human
travel is a major contributing factor to the geographical spread of
dengue viruses. The most common vector, Aedes aegypti, although
African in origin has spread throughout the world; a result of trade
and increased human travel.3
DF is an illnesswith profound social, economic, and health costs
to society.4 In many developing tropical countries outbreaks are a
huge economic burden.5 Dengue emerged as a major public health* Corresponding author. Tel.: +92 3336103130.
E-mail address: doctormalikasif@gmail.com (M.A. Humayoun).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.10.008burden in Southeast Asia after the SecondWorldWar and has now
become more important, with progressively longer6 and more
frequent epidemics of DF/DHF in this part of theworld. Despite this
trend, surveillance for this vector-borne viral disease remains
largely passive in most Southeast Asian countries. The most
worrisome problem of dengue resurgence is that it comes with
increased frequency, severity and a high incidence of DHF, a severe
complication of this disease that usually arises upon re-infection
with a different serotype.7 In contrast to DF, which is usually a self-
limiting viral illness, DHF is a serious complication of dengue
infection with signiﬁcant morbidity and mortality.8
Outbreaks of dengue follow a predictable epidemiological
pattern; frequent transmission of the virus with sporadic cases of
DHF, followed by increasingly frequent outbreaks that steadily
increase in size, eventually establishing a pattern of epidemics
occurring every 2–5 years, with sporadic cases in the intervening
periods. In the past, outbreaks of a variety of viral hemorrhagic
fevers (VHF) including DHF have been reported in Pakistan. Theses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Demographic proﬁle of dengue cases during the 2008 outbreak in Lahore,
Pakistan.
Figure 2.Duration of fever among dengue cases during the 2008 outbreak in Lahore,
Pakistan.
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Karachi in 1994 and in the following year an epidemic of DF
occurred in Baluchistan.9,10 Later, a large outbreak occurred in
Pakistan in 2006; Khan et al. reported co-circulation of DEN2 and
DEN3 serotypes during this 2006 outbreak in Karachi.11 Recently, a
change in the pattern, clinical spectrum, and outcome of this
disease has been reported, with an increased incidence of DHF in
clinical practice.12,13 Also, during recent outbreaks in Asia, it has
been noted that DHF is becoming increasingly common, that the
circulation of multiple serotypes appears to be established, and
that outbreaks of DHF have become more frequent.14,15
Although dengue has become the most important vector-borne
disease in Pakistan over the last decade, published scientiﬁc
research dealing with the local situation regarding the pattern of
clinical disease is limited. We therefore conducted a study to
investigate the clinical and pathological proﬁle of the patients with
dengue viral infection during the 2008 outbreak in Lahore in order
to assess the disease severity and to better understand the clinical
pattern of the disease in Pakistan.
The objective of this study was to investigate the clinical and
pathological proﬁle of subjects suffering from dengue viral
infection presenting to two tertiary care teaching hospitals in
Lahore, Pakistan during the 2008 outbreak. The variables
investigated were the most common clinical features, disease
progression, grades of disease severity, and outcome.
2. Materials and methods
From September to December 2008, we collected and analyzed
the clinical and laboratory data of 110 patients from the special
dengue wards of the two tertiary care teaching hospitals in Lahore,
after obtaining informed consent. The study was approved by the
Ethics Committee of Allama Iqbal Medical College and Jinnah
Hospital, Lahore, Pakistan.
A subject was deﬁned as having a ‘suspected’ case of dengue
virus infection if they gave a history of acute onset fever with
constitutional symptoms, thrombocytopenia, and a positive IgM
alone or positive IgG antibody test. A ‘conﬁrmed’ case of acute
dengue viral infection was deﬁned as a suspected case with either
positive dengue virus serotyping on real-time polymerase chain
reaction (RT-PCR) or a four-fold or greater rise in IgM or IgG
antibody titer in a paired serum sample. Only conﬁrmed cases of
dengue from these two tertiary care hospitals were included in our
study. All conﬁrmed cases of dengue viral infection were classiﬁed
into one of three subtypes – DF, DHF, and dengue shock syndrome
(DSS) – on the basis of their clinical and pathological proﬁle, using
the World Health Organization (WHO) criteria.16
Cases were classiﬁed as DHF if they met the four necessary
criteria, i.e., fever or recent history of acute fever, hemorrhagic
manifestations, low platelet count (100  109/l), and objective
evidence of ‘leaky capillaries’ (evidenced by elevated hematocrit
(20% or more over baseline), low albumin, pleural or other
effusions, and a positive tourniquet test). Subjects meeting the
criteria of DHF with evidence of circulatory failure manifested by a
rapid and weak pulse, narrow pulse pressure (20 mmHg) or
hypotension for age, cold clammy skin, and altered mental status
were classiﬁed as DSS.
Laboratory investigations were performed on admission and
throughout the hospital stay. Laboratory tests included full blood
count, prothrombin time, activated partial thromboplastin time
(APTT), blood urea nitrogen, serum creatinine, serum bilirubin,
aspartate aminotransferase (AST), alanine aminotransferase (ALT),
serum protein, serum albumin, serum electrolytes, urinalysis, anti-
dengue IgM and IgG by ELISA, and dengue serotype by PCR. Dengue
RNA was isolated from the serum by QIAmp Ultra-sense RNA Mini
Kit (Qiagen, Valencia, CA, USA). Dengue RNA in the patient samplewas ampliﬁed by the Qiagen Dengue Real Time PCR Kit (Qiagen)
using the speciﬁc standard on Rotor-Gene (Qiagen). In the RT-PCR,
the ampliﬁed product was detected using ﬂuorescent dyes. These
were linked to oligonucleotide probes that were bound speciﬁcally
to the ampliﬁed product. Monitoring the ﬂuorescence intensities
during the PCR run allowed the detection and quantitation of the
accumulating product without having to re-open the reaction
tubes after the PCR runs. Serotyping analysis was performed on the
same ampliﬁed product and was followed by a melt curve analysis
to differentiate the dissociation points of each serotype for dengue
virus cDNA. The sensitivity of this dengue assay is 98% and the
speciﬁcity is 99%.
Clinical information and laboratory abnormalities of patients
with conﬁrmed dengue infection were collected by trained
researchers on a data collection sheet. Data were compiled and
analyzed anonymously using SPSS v.11 (SPSS Inc., Chicago, IL, USA).
3. Results
A total of 483 suspected cases of dengue viral infection were
admitted to the special denguewards of the two teaching hospitals
during the study period. One hundred and ten conﬁrmed dengue-
infected cases aged 15 years and above were enrolled in our study.
Seventy of the 110 subjects weremale (63.6%). All adult age groups
were represented (Figure 1). The total duration of fever, day of
presentation after onset of symptoms, and total duration of
hospital stay are shown in Figures 2–4, respectively.
Figure 3. Day of presentation after onset of dengue fever symptoms.
Table 1
Clinical manifestations of the 110 hospitalized cases during the 2008 dengue virus
outbreak in Lahore, Pakistan
Clinical features Frequency Percentage
Fever 110 100%
Rash 57 51.8%
Epistaxis 17 15.5%
Bruise 11 10%
Hematuriaa 10 9.1%
Gingival bleed 9 8.2%
Hemoptysis 6 5.5%
Hematemesis 3 2.7%
Vaginal bleed 3 2.7%
Hematochezia 3 2.7%
Any hemorrhageb 1 0.9%
a Microscopic hematuria deﬁned as more than ﬁve red blood cells per high-
power ﬁeld.
b One person developed retinal hemorrhage.
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dengue viral infection, i.e., fever,malaise andmyalgias, retro-orbital
pain, and skin rash or any hemorrhagic manifestation. The most
common symptoms were fever (100%), myalgia (68.2%), headache
(55.5%), nausea (39.1%), non-hemorrhagic skin rash (53.6%),
mucocutaneous hemorrhagicmanifestations (58.2%), and eye strain
andretro-ocularpain (20%).Patientsweremostly referred fromtheir
local general practitioner or primary healthcare center.
On examination, the most common ﬁndings included tachy-
cardia, fever, and slight reduction in blood pressure. Frank
hypotension was noted in only two patients. Pleural effusion
and hepatomegaly was noted in 31 (28.2%) patients. None of the
patients developed ascites or pericardial effusion. No focal
neurological deﬁcits or altered state of consciousness was
observed in any subject.
Cutaneous manifestations were present in 64.5% of patients.
The most common observation was a maculopapular or a
morbilliform eruption in 53.6% and a hemorrhagic skin rash like
purpura, ecchymoses or petechial rash in 51.8%. A non-hemor-
rhagic cutaneous rashwas alsomore common in patientswithDHF
as compared to DF. Overall, hemorrhagic manifestations, noted in
64 (58.2%) patients, were usually mild. These included hemor-
rhagic skin rash in 51.8%, epistaxis in 15.5%, bruises in 10%,Figure 4. Total hospital stay of dengue cases during the 2008 outbreak in Lahore,
Pakistan.hematuria in 9.1%, gingival bleed in 8.2%, hemoptysis in 5.5%,
hematemesis in 2.7%, vaginal bleed in 2.7%, hematochezia in 2.7%,
and subconjuctival hemorrhage in only 0.9% of the patients (Table
1). Only 3.6% of cases had severe hemorrhagic complications, but
they responded well to intravenous ﬂuids, platelet concentrates,
and whole blood transfusions.
The total duration of fever ranged from 3 to 16 days, while the
mean duration of fever was around 6 days. Two patients developed
a nosocomial infection during their stay in hospital. Fever
responded well to antipyretic therapy and no speciﬁc pattern
was observed. None of the patients developed seizures, meningo-
encephalitis, or encephalopathy.
Among the laboratory abnormalities, thrombocytopenia, a low
total leukocyte count, raised hematocrit, and deranged liver
function tests were frequently encountered. Abnormal serum
creatinine was found in 10/92 (10.9%) of the cases. There was no
speciﬁc association of these laboratory abnormalities with age,
gender or grade of fever, but a deﬁnitive association was found
with the type of dengue clinical syndrome. Thrombocytopenia,
leukopenia and abnormal AST/ALT were more frequently encoun-
tered in DHF/DSS as compared to DF (Table 2). Out of 110 patients,
46 were diagnosed as cases of DF, while 62 were diagnosed as DHF
and two as DSS.
DHF was more common among males as compared to females
(Table 3). Out of the 62 DHF cases, 10 were grade 1, while 52 were
grade 2, according to the WHO severity grading for DHF. The two
cases of DSS were of grade 3 severity. The proportion of dengue
clinical syndromes and severity of diseasewas similar in the young
and old age groups. A total of 17 patients had their viral RNA
detected by RT-PCR and had serotyping done. Three different
serotypeswere detected in this small number of patients. Ten of 17
were of DEN4 serotype, while 5/17 were serotype DEN2 and 2/17
were serotype DEN3.
4. Discussion
Our study shows that all adult age groups (15 years) were
equally infected by dengue infection, although a slightly increased
frequency was found in the age group 20–30 years. Overall, the
outcome for patients was good, and neither the young nor the old
were speciﬁcally found vulnerable to complications. However, it is
very important to include the pediatric age group for accurate
assessment of age distribution patterns in dengue. In this study, we
focused only on adults presenting with dengue infection, so we
cannot compare the incidence of infection between the adult and
pediatric age groups for this outbreak. In future studies, we intend
to include pediatric subjects with dengue infection in order to
understand the whole disease proﬁle. However, an unpublished
Table 2
Comparison of laboratory characteristics between the three dengue clinical syndromes in the 2008 outbreak in Lahore, Pakistan
Hemoglobin (%) White cell
count ( 109/l)
Platelet count ( 109/l) Hematocrit AST ALT Serum
protein
Serum
albumin
DF 12.51.67 5.4522.203 112.73929.174 38.37 12136 12541 6.750.57 3.39 0.46
(9.8–17) (1.700–10.000) (50.000–190.000) (25–210) (35–230) (5.1–7.8) (2.1–5.2)
N 46 46 46 32 44 43 40 43
DHF 12.742.32 4.0472.191 47.86124.080 416.5 126.5+56.5 125.761 6.50.64 3.07 0.43
(8.50–17.3) (0.800–10.000) (2.700–97.000) (29–54) (25–230) (28–245) (4.9–8.0) (1.9–4.0)
N 62 62 62 49 46 47 33 46
DSS 11.553.46 2.200 0.141 17.5000.707 27 176.575.6 193.594 5.50.70 2.95 0.07
(9.1–14) (2.100–2.300) (17.000–18.000) (123–230) (127–260) (5–6) (2.9–3.0)
N 2 2 2 1 2 2 2 2
Total 12.632.075 4.6002.296 74.44041.908 39.766.22 124.8248.4 126.953.6 6.630.64 3.22 0.47
(8.5–17.3) (0.800–10.000) (2.700–190.000) (27–54) (25–230) (28–260) (4.9–8) (1.9–5.2)
N 110 110 110 82 92 92 75 91
Results are mean standard deviation (range).
DF, dengue fever; DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; AST, aspartate aminotransferase; ALT, alanine aminotransferase.
Table 3
Sex distribution of dengue clinical syndromes during the 2008 outbreak in Lahore,
Pakistan
Dengue clinical syndrome
DF DHF DSS Total
Sex of patient
Female 22 (20%) 18 (16.4%) – 40 (36.4%)
Male 24 (21.8%) 44 (40%) 2 (1.8%) 70 (63.6%)
Total 46 (41.8%) 62 (56.4%) 2 (1.8%) 110 (100%)
Results are n (% of total).
DF, dengue fever; DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome.
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outbreak in Punjab, revealed that out of 1407 reported cases, 785
were under 15 years of age (source: data obtained through
personal communication with Punjab’s focal person for the
prevention and control of dengue fever and the director of Dengue
Cell, D.G. Ofﬁce Punjab, Dr Zafarul Islam). This shows that the
majority of the cases were reported in the pediatric age group
during this outbreak. Qureshi et al., studied hospital admitted
cases during the course of an outbreak of dengue viral fever in
Karachi, Pakistan from June 1994 to September 1995 and reported
a higher frequency of DF in the younger population.17 A report
from India revealed that the highest incidence during the 2003
outbreak in Delhi was among young adults,18 whereas various
previous studies have reported the highest incidence in children.19
In Southeast Asia (e.g., Thailand and the Philippines), children are
most likely to be affected.19 However, in areas of lower endemicity,
such as the Americas, any age groupmay be affected,20,21 although
the incidence has been reported to be higher in children under
15 years of age.
The majority of patients presented within the ﬁrst 5 days of
the onset of fever, which seems to be due to better public
awareness as a result of a very active media campaign. The
duration of fever was less than 10 days in the majority of patients
(94.5%), while a few patients (5.5%) had a prolonged duration of
fever (i.e., 10–16 days). This ﬁnding is in contrast to various other
previous studies of DF, where the usual duration of fever is
reported as being up to 10 days.22 All of the patients having a
prolonged duration of fever in our study had relatively more
severe disease with a prolonged hospital stay. A characteristic
ﬁnding among these patients was a persistently high level of
aminotransferases. All of these patients were also investigated
extensively for any other possible cause of prolonged fever, but
no other cause of fever was found. Two out of these six patients
with a prolonged duration of fever were inWHO severity grade 3,
while four patients were in severity grade 2.Fever was the most common presenting complaint, while non-
hemorrhagic skin rash and hemorrhagic mucocutaneous mani-
festations like petechiae and epistaxis were also not uncommon as
the initial presentation. The most common ﬁndings included
tachycardia, fever, and a slight reduction in blood pressure, while
hepatomegaly, ascites and pleural effusion were not encountered
frequently. Neither focal neurological deﬁcits nor an altered state
of consciousness was observed in any of the patients.
Leukopenia, thrombocytopenia, and low serum albumin
affected patients in a similar fashion as reported from other parts
of Asia,15,18,23 but an increase in hematocrit was not as commonly
seen as in various other studies. This may be because of the judicial
use of ﬂuids and supportive therapy in the hospital. Thrombocy-
topenia and leukopenia were more frequently encountered in DHF
and DSS as compared to DF. Another very commonly observed
ﬁnding was an asymptomatic elevation of liver enzymes, again
more frequently encountered in DHF and DSS as compared to DF,
and this has also been reported by Faridi et al. in India.23
Multicenter studies integrating different centers in Asia may be
beneﬁcial to better understand the changing trends in clinical
presentations speciﬁc to the region. In our study, only 3% of
patients developed acute renal failure, lower than the 5% incidence
reported by Lee et al.8 This could be explained by the fact that
patients in our study were younger and patients presented earlier
during the course of infection. Hence, early recognition of the
clinical features and early ﬂuid repletion may play a key role in
preventing life-threatening complications.
In our study, a large proportion of hospitalized dengue patients
(58.2%) developed hemorrhages. Previous hospital-based studies
from other countries of this region, as well as from Pakistan, have
revealed relatively lower rates of hemorrhagic manifestations
when compared with our study.16,17,24
A decade-wise analysis of data on DF from America showed a
steady increase in the proportion of DHF. Similarly if we go
through the limited data of dengue outbreaks in Pakistan, we see
an increase in the incidence and severity of this disease in clinical
practice. Chan et al. reported the ﬁrst conﬁrmed outbreak of DHF
in Karachi, which occurred in 1994.9 The following year, in 1995,
an epidemic of DF among employees of a construction contractor
at a power generation plant in Baluchistan was reported.10 This
was an outbreak of DF due to multiple serotypes of dengue virus.
The frequency of DHF was less documented in Pakistan until a
large outbreak occurred in Karachi in 2006 when Khan et al.
reported co-circulation of DEN2 and DEN3 serotypes during this
outbreak in Karachi.11 Primary and secondary cases were also
found in both groups. During this outbreak, Ahmed et al. reported
only two cases of DHF out of 40 conﬁrmed dengue cases.13
Recently, a change in pattern, clinical spectrum, and outcome of
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incidence of DHF in clinical practice at tertiary care hospitals in
Karachi.12,13 All previous studies of DF in Pakistan have mainly
been reported from Karachi. So far no dengue data have been
reported from Lahore, which is the second most populous city of
Pakistan and also the capital of the Punjab, which is the most
populous province of Pakistan. This is the ﬁrst reported outbreak
of DF from Lahore.
According to an unpublished provincial report of conﬁrmed
dengue cases from 2008, produced by the Dengue Cell, D.G. Ofﬁce
Punjab, therewere 113 conﬁrmed cases of dengue viral infection in
2006 and 232 cases in the year 2007. Three deaths occurred in the
whole of Punjab during this period due to complicated dengue
infection. The ﬁgures for 2008 were very high, with 1407 cases
reported from all over Punjab; nine deaths were reported due to
complicated dengue infection (source: data obtained through
personal communication with Punjab’s focal person for the
prevention and control of DF and director of the Dengue Cell,
D.G. Ofﬁce Punjab, Dr Zafarul Islam). Similarly, the number of cases
admitted to the special dengue ward of one of the two tertiary care
hospitals was also very high as compared to previous years. There
were 63 admissions in 2006 and 71 in 2007, while the number of
admissions in 2008 was 293. This may indicate a trend towards a
higher frequency of dengue infection with increased severity
during this outbreak.
In our study more than half of the patients with a dengue viral
infection presented with DHF. The high percentage of DHF
amongst hospitalized patients during the 2008 dengue outbreak
as compared to previous years is indeed alarming. A comparison of
these data with those from previous years indicates a shift from
mild illness towards a more severe manifestation of the disease,
which could be interpreted as an epidemiologic transition pattern
andmay be a sign of hyperendemicity of the dengue virus in Lahore
and possibly other regions of the country.
In South Asia, all dengue serotypes have circulated periodically.
The presence of genotypes 2 and 3 were revealed in Karachi during
the 2006 outbreak,11 but in addition to serotypes 2 and 3, we also
found 10 cases of serotype 4. Locally acquired DHF with three
different serotypes has only been reported recently in our study.
The introduction of a new serotype (DEN4) and/or a genotypic shift
of endemic serotypes (DEN2, DEN3) may have been the factors
involved in the recent outbreak of DHF in this region. A large
number of conﬁrmed dengue cases during the 2008 outbreak in
Lahore indicates that a substantial proportion were infected with
the dengue virus, and because of the multiple dengue serotypes,
this population might be even more susceptible to DHF if they
receive a subsequent infection with a heterologous dengue
serotype in the coming years.
In Pakistan, serologic and virologic conditions are now highly
indicative of a locally acquired outbreak of DHF of a large
magnitude in the future, so prevention of DF and the control of
vectors have become increasingly important. Several simple steps
can be taken to reduce themorbidity andmortality associatedwith
dengue viral illness. Apart from vector control, continuing
education of clinicians and primary care physicians is crucial for
early recognition of DHF, especially in those patients with a prior
history of DF. A careful history should be obtained from patients
with a suspected dengue virus infection to ascertain the extent of
illness during any previous dengue infection. This would help
identify patients at high risk for developing DHF and DSS.
Even though dengue infection has contributed to a signiﬁcant
proportion of tropical illnesses in Pakistan, it has not received its
due share of attention until recently. One of the aims of this study
was to assess whether dengue infection is more than just a simple
self-limiting viral infection. As it turns out, all the patients did
eventually recover, although more than half did develop DHF, amore severe form of dengue infection. This ﬁnding is contrast to
what practicing physicians believe. Our study has the potential to
divert signiﬁcant public healthmonies towards early detection and
treatment. Last year, for the ﬁrst time, the Government of Punjab
offered free screening and treatment to the public and designated
‘dengue wards’ in all tertiary care hospitals. Our study will help
reinforce the resolve of the Government to continue to strive for
prevention and treatment of uncommon yet dangerous tropical
diseases such as DF.
Since this was a hospital-based study, it does not reﬂect the
true burden of dengue in our community. Community infection
with DF is characterized by the ‘iceberg’ or pyramid phenomenon.
At the base of the pyramid, most of the cases are asymptomatic,
followed in increasing rarity by DHF and DSS. Since we had a
higher number of patients with DHF than the ones with
undifferentiated fever in our study population, one can postulate
from this study that the base formed by undifferentiated fever
may be very large, and thus the endemicity of dengue in the
community could be quite high. It is therefore suggested that
there is the need for further large clinical studies in Pakistan and
other countries of the region to better understand the clinical
spectrum, endemic pattern, and population genetics of dengue
viral infection.
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